background image

Paid Clinical Trials West Virginia

Discover 370 paid clinical trials in West Virginia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Real-World Efficacy of Evoke® Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Chronic Pain Patients (ULTRA).

Recruiting

Sponsor:

Saint Francis Hospital

Location:

Charleston WV

Code:

NCT06246526

Conditions

Pain

Chronic Pain

Neuropathic Pain

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Evoke

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

Recruiting
PHASE3

Sponsor:

Icahn School of Medicine at Mount Sinai

Location:

Charlottesville VA, Falls Church VA, Washington DC, Bethesda MDshow 45 more

Code:

NCT04045665

Conditions

Atrial Fibrillation

Stroke

Bleeding

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Antiplatelet-only strategy

Oral Anticoagulant plus background antiplatelet therapy

A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

Recruiting
PHASE3

Sponsor:

Eli Lilly and Company

Location:

Richmond VA, Chantilly VA, Oxon Hill MD, Arlington VAshow 172 more

Code:

NCT05026866

Conditions

Alzheimer Disease

Eligibility Criteria

Sex: All

Age: 65 - 70+

Healthy Volunteers: Not accepted

Interventions

Donanemab

Placebo

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting
PHASE3

Sponsor:

NRG Oncology

Location:

Charlottesville VA, Midlothian VA, Richmond VA, Mechanicsville VAshow 706 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

Recruiting
PHASE3

Sponsor:

Bayer

Location:

Richmond VA, Fairfax VA, Annapolis MD, Baltimore MDshow 46 more

Code:

NCT04464226

Conditions

Cancer

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Darolutamide (Nubeqa, BAY1841788)

A Study to Investigate the Effect on Lung Function of BDA Formulated With a New Propellant (HFO) Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Burke VA, Washington DC, Portsmouth VA, Raleigh NCshow 62 more

Code:

NCT06502366

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BDA MDI HFO 160/180 μg

BDA MDI HFA 160/180 μg

Placebo MDI HFA

Use of Transmucosal Ketamine in Post Stroke Depression

Recruiting
PHASE1

Sponsor:

West Virginia University

Location:

Morgantown WV

Code:

NCT04876066

Conditions

Post-stroke Depression

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ketamine

SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

Recruiting

Sponsor:

Medtronic Vascular

Location:

Charlottesville VA, Washington DC, Durham NC, Baltimore MDshow 67 more

Code:

NCT05198674

Conditions

Hypertension

Vascular Diseases

Cardiovascular Diseases

Chronic Kidney Diseases

Diabetes Mellitus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Renal Denervation (Symplicity Spyral™)

Randomized Trial Comparing Diltiazem and Metoprolol For Atrial Fibrillation Rate Control

Recruiting

Sponsor:

CAMC Health System

Location:

Charleston WV

Code:

NCT02025465

Conditions

Atrial Fibrillation

Atrial Flutter

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Metoprolol

Diltiazem

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus (AMETHYST)

Recruiting
PHASE2
PHASE3

Sponsor:

Biogen

Location:

Richmond VA, Durham NC, Chapel Hill NC, Greensboro NCshow 51 more

Code:

NCT05531565

Conditions

Subacute Cutaneous Lupus Erythematosus

Chronic Cutaneous Lupus Erythematosus

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Litifilimab

Placebo

Popular cities in West Virginia